This brief summarizes the contributions of Kaiser Permanente Research since 2007 on the topic of diabetes, including type 1, type 2, and gestational diabetes.
be at greater risk of diabetes themselves. 8 Factors that reduce diabetes risk, such as weight loss, 9 have also been the subject of Kaiser Permanente research.
Gestational diabetes is an important health concern for pregnant women. One Kaiser Permanente study using data from 1999-2005 reported a stable prevalence of gestational diabetes among our members, after adjusting for the increasing prevalence of pre-existing diabetes. 10 Factors that increase the risk of developing gestational diabetes [11] [12] [13] [14] [15] have been studied widely, as has risk of recurrence of gestational diabetes in subsequent pregnancies, 15 and the risk of sustained glucose dysregulation after pregnancy among women with a history of gestational diabetes. [16] [17] [18] [19] [20] Among youth, Kaiser Permanente researchers have found significant increases over time in both incidence and prevalence of type 1 and type 2 diabetes, 21, 22 with minorities impacted more heavily. A substantial volume of work has addressed diabetes risk factors among youth, including dietary, physical activity, and weight loss factors, [23] [24] [25] [26] [27] as well as risks linked to maternal gestational diabetes status and other perinatal and neonatal factors. 28, 29 What other health risks do people with diabetes face?
People with diabetes face added health risks, including risks related to the use of medications for treating diabetes. Kaiser Permanente research scientists have authored studies evaluating the risks of complications of diabetes (for example, nephropathy, neuropathy, or retinopathy) and common comorbidities (for example, hypertension or arterial stiffness), [30] [31] [32] [33] [34] the risk of developing various cancers [35] [36] [37] [38] [39] [40] and the risk of bone fractures. 41, 42 In children with type 1 or type 2 diabetes, these complications and comorbidities often appear as early as adolescence and early adulthood, with a greater burden among those with type 2 diabetes. 43, 44 Studies have also demonstrated an increase in dementia risk for people with diabetes who have experienced hypoglycemic
Understanding Risk
Kaiser Permanente researchers have contributed to understanding the risk of developing diabetes, as well as the other risks that people with diabetes face.
Who is at risk for developing diabetes?
In adults, we have studied who is most at risk for developing type 2 diabetes. A selection of the risk factors for diabetes that Kaiser Permanente studies have assessed includes body mass index, 3 fasting plasma glucose levels, 4 use of antidepressant medications, 5, 6 and use of antihypertensive medication combination therapy. 7 Those whose spouses or partners are diagnosed with diabetes have been found to This study focused on patients with type 2 diabetes and either existing cardiovascular disease or heightened risk for it. The trial randomized over 10,000 patients to intensive glucose lowering therapy (HbA1c goal of 6.0) versus standard therapy (goal of 7.0-7.9), and followed them for nonfatal heart attack or stroke, and fatal cardiovascular events over an average of 3.5 years of follow-up.
Diabetes Remission for Patients With Type 2 Diabetes Who Received Bariatric Surgery Versus Non-Surgical Approaches
The authors found that intensive glucose lowering was associated with increased mortality, and did not reduce the risk of nonfatal cardiovascular events. They concluded that this study uncovered a previously unrecognized harm associated with intensive glucose control for high-risk patients.
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Joshua I. Barzilay, MD R. James Dudl, MD episodes, those with poor glucose control, and those with comorbid depression. [45] [46] [47] [48] [49] Kaiser Permanente research has also investigated risks related to chronic conditions that are often comorbid with diabetes, such as pulmonary, kidney and cardiovascular diseases. 36, [50] [51] [52] [53] [54] One increasingly common risk-mitigation strategy for people with diabetes and obesity is bariatric surgery. Studies have shown that -particularly for people who are less severely obese -bariatric surgery can result in diabetes remission and a host of related benefits, [55] [56] [57] [58] [59] [60] including improved life expectancy. 61, 62 Even for people who experience a relapse of diabetes after a period of remission, the remission has been linked to longer-term health benefits, such as reduced risk of microvascular complications of diabetes. 55 Also important are the risks for babies born to women who experience gestational diabetes, as well as those with type 1 or type 2 diabetes. Among these risks are fetal and neonatal macrosomia, [63] [64] [65] [66] impaired glucose tolerance, 67 hypoglycemia, 66 hyperbilirubinemia, 66 childhood obesity, [68] [69] [70] [71] and development of autism 72, 73 and ADHD. 74
Improving Patient Outcomes
What strategies are effective in preventing diabetes?
For people at risk of type 2 diabetes, making a timely diagnosis of prediabetes creates an opportunity to encourage lifestyle changes that can reduce the risk of developing diabetes. 75, 76 Kaiser Permanente researchers have studied the performance of various approaches to detecting prediabetes, 77, 78 
How does early identification of diabetes affect outcomes?
Early diagnosis of diabetes relies on screening of people at risk. Early recognition of type 1 and type 2 diabetes can confer substantial treatment and outcome benefits. For example, people who are diagnosed early can enter treatment before consequences of uncontrolled diabetes occur, such as diabetic ketoacidosis. 84 What are the key factors in effective treatment of people with diabetes?
Glucose Control. For people with diabetes, glucose control -through self-management activities including lifestyle adaptations, self-monitoring of blood glucose, and medication adherence -is essential to effective treatment. 85, 86 Our research has emphasized the value of addressing food insecurity among patients with diabetes, as this has been linked to poor diabetes control and higher rates of hospitalizations and emergency room visits. 87 Diabetes-care guidelines suggest an escalating medication treatment strategy for people with type 2 diabetes based on glucose control and responsiveness to medications. However, medications are not always escalated as recommended, even when glycemic control is inadequate, 88, 89 in part because of barriers to insulin initiation, 90,91 medication costs, 92 and the complexity of the medication regimen. 93 Use of common glucose-lowering medications in the management of gestational diabetes is controversial, as their safety in pregnant women has not been clearly established, 94 and the use of insulin during pregnancy is frequently a negative, anxiety-provoking experience. 95 In young adults with childhood-onset diabetes, glucose control may be adversely affected during the transition between pediatric and adult primary care. 96 For most adults with diabetes, treatment is directed to maintain an HbA1c less than 7%. Kaiser Permanente studies have compared the effectiveness of alternative insulin regimens 97-100 and glucose control targets. 101 In particular, researchers have recently studied the appropriateness of low glycemic targets for older adults and concluded that relaxing glucose control targets (for example, up to HbA1c of 7.5%) for older adults can avoid hypoglycemic events and other adverse outcomes, with few negative consequences. [102] [103] [104] Other work conducted by our scientists has found that glycemic control can be improved in Latino patients with limited English proficiency by matching them to bilingual primary care physicians. 105 Such real-world studies in our large membership provide valuable insights that complement clinical trials, 106 which frequently exclude older adults and people with comorbidities.
Complications of Diabetes.
Appropriate screening for serious complications of diabetes is an essential component of effective treatment.
Recommended processes of care include eye exams, foot exams, and influenza immunizations. Kaiser Permanente studies have shown that documentation of these care processes is incomplete in administrative claims data, 107 and have also measured the impact of insurance continuity or coverage type on receiving recommended preventive care. 108, 109 Even among insured people, gaps in recommended care processes are common for adults 110, 111 but are less problematic among youth. 112
Comorbid Conditions. People with diabetes and multiple comorbid conditions face added challenges and risks. One of these is polypharmacy: the concurrent use of multiple prescription medications. Kaiser Permanente research has demonstrated that medication burden increases substantially for adult patients newly diagnosed with diabetes. 113 Polypharmacy is linked with decreased medication adherence 114 and increased medication interactions. 115 Furthermore, polypharmacy has been associated with patient falls in studies focusing on adults with diabetes. 116 In addition, chronic and acute conditions can be more difficult to treat in the context of diabetes than for people without diabetes. For example, surgical care of patients with diabetes and surgical treatment of diabetic foot infections is complicated by microvascular diseases that inhibit wound healing. 117, 118 Studies have also demonstrated that people with comorbid diabetes and hypertension, hyperlipidemia, and hyperglycemia often experience both treatment non-adherence and lack of appropriate treatment intensification for these comorbidities, leading to worse outcomes. [119] [120] [121] 
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Notable Studies and Clinical Trials Focusing on Diabetes
Translating Research Findings Into Policy and Practice How has Kaiser Permanente research contributed to changes in policy and practice?
Kaiser Permanente is a learning health care system that works to systematically use research to inform and improve practice both within Kaiser Permanente and more broadly.
Within Kaiser Permanente, research, clinical, and operational partners have tested a range of interventions to prevent diabetes or improve diabetes outcomes. These have included strategies such as education, wellness, and behavior change programs focused on exercise, diet, and medication adherence, [122] [123] [124] [125] collaborative care programs for patients with diabetes and comorbid behavioral health problems, [126] [127] [128] [129] [130] pharmacist-led diabetes management, 131 workplace screening and wellness programs, 122, 132 and educational interventions specifically for women with gestational diabetes 133 and youth. 80 Within Kaiser Permanente, studies have also evaluated the role of electronic medical records (and other data assets) in improving quality of diabetes care, identifying diabetes medication nonadherence, recognizing prediabetes, and other outcomes. [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] Disease management programs, often offered by third-party vendors, are increasingly popular in the United States, and are widely used by state Medicaid programs and others. Our studies assessing online and telephonic disease management or coaching programs have found that they can be effective but are not uniformly so. 123, 144, 145 Furthermore, these programs have been shown to face challenges related to low uptake among eligible individuals who might benefit 146 and suboptimal levels of engagement with the platform over time. 147 Researchers have also found that linking these efforts back to primary care is challenging, even in an integrated care setting with an advanced electronic medical record system. 148, 149 Kaiser Permanente research contributes not only to policy and practice change within our own delivery system, but has also advanced the national understanding of diabetes. To date, Kaiser Permanente authors have been cited more than 400 times within recent consensus statements and clinical practice guidelines published by a wide range of entities, including the American Diabetes Association, American Heart Association, and the American Geriatrics Association, among others. In addition, Kaiser Permanente research and clinician scientists have directly contributed as authors of practice guidelines and systematic reviews. These include reviews published by the U.S. Preventive Services Task Force, 150 and the Kaiser Permanente's nearly 170 research scientists and more than 1,600 support staff are based at 8 regional research centers and one national center. There are currently more than 2,400 studies underway, including clinical trials. Since 2007, our research scientists and clinicians have published more than 12,000 articles in peer-reviewed journals. Kaiser Permanente currently serves more than 12. American Association of Clinical Endocrinologists and American College of Endocrinology's consensus statements on the type 2 diabetes management algorithm. [151] [152] [153] Finally, our scientists have co-authored a report on research gaps in gestational diabetes for the National Institute of Diabetes and Digestive and Kidney Diseases. 154 Each of Kaiser Permanente's regional research centers participates in the Health Care Systems Research Network (HCSRN), a national research network that aims to improve individual and population health through research. 155 The SUPREME-DM study, focused on diabetes and led by a Kaiser Permanente researcher, is one of HCSRN's cornerstone projects. Kaiser Permanente researchers have led or collaborated on many more notable studies and trials related to diabetes epidemiology, prevention, risk factors, and treatment.
